In the early years of the HIV/AIDS epidemic the notion of combating the disease by the traditional approach for controlling other sexually transmitted diseases-that is, tracing contacts and notifying partners-met with heated debate.
Though most health care workers agreed that all people infected with HIV should inform their sexual partners and those with whom they shared needles (that is, patient referral), many believed health care providers should not do the informing (that is, provider referral). Concerns were loss of confidentiality, the potential for stigmatisation of infected people, and the fear of alienating those who might otherwise have come forward for testing balanced against the rights of exposed subjects to be informed of their risk and identified. ' At that early stage the natural course of the infection was poorly understood, no treatments were available, and it had not been established that personal counselling for high risk contacts resulted in sustained change in behaviour. Opponents of notification of partners believed that national education campaigns were adequate; proponents believed that these messages were not necessarily reaching people who did not suspect they were at risk.
But the situation has evolved. In the United States, Canada, Belgium, and Scandinavia notification of partners has gained favour as a legitimate approach to managing HIV infection as a result of evidence of the changing epidemiology of the infection and studies showing the beneficial effects of early antiviral treatment and prophylaxis for opportunistic infections.7'"
In the United Kingdom medical staff in genitourinary medicine clinics have the major responsibility for managing people with early HIV infection. The only official guidelines for tracing contacts are those for the common sexually transmitted diseases, which were published in 1980, before the HIV epidemic emerged. 12 Therefore, to examine attitudes and practices regarding the notification of partners in the United Kingdom we surveyed consultant physicians and health advisers in genitourinary medicine clinics.
Subjects and methods
In October 1991 we sent a questionnaire to 146 consultant genitourinary physicians who were readily identified as working in 204 The questionnaire had three parts. The first requested demographic information, details of work experience, and the number of health advisers working in each clinic. Other questions inquired about training for dealing with sexually transmitted diseases and HIV counselling, access to guidelines; policies for offering HIV antibody tests, counselling practices before and after testing, and the extent to which health advisers were directly involved in referral of partners.
In the second part participants were asked if they agreed with statements about the effectiveness of partner notification programmes. Opinions were canvassed on a five point Likert-type scale (strongly agree, agree, uncertain, disagree, strongly disagree) which was subsequently converted to a three point scale because the response frequencies of the extreme categories were small. There was a low non-response rate for these items (1-4% among consultants and 0-5% among health advisers).
Finally, respondents were asked for their recommendations for counselling contacts of people in a series of hypothetical situations of high risk HIV exposure. The allowable responses were agree, uncertain, and disagree. The non-response rates for these questions were not trivial, particularly among the health advisers (7-12%) , and non-response was included as a fourth category for the analyses.
As health advisers provide most of the counselling and the physicians are responsible for clinic policies we were interested to know whether their opinions differed. Also, because the four Thames regions have reported three quarters of HIV/AIDS cases in England and Wales, we compared the opinions and practices of staffin these high prevalence areas with those of staffin the rest of the United Kingdom. '3 The analyses reported in 12 (8%) were trained principally in counselling and social work, and 27 (19%) had "non-medical" qualifications. Health advisers in the Thames regions and those outside had similar qualifications. Physicians and health advisers differed in their work histories: 63 (60%) physicians had worked in genitourinary medicine for more than 10 years compared with only 27 (19%) health advisers (p<000001), and they had been in their present posts for longer (mean 9-3 v 4-3 years).
HIV antibody tests were available in almost all clinics and only a few staff would never offer the test to clients (table I) . Physicians were significantly more likely than health advisers to offer the test to selected clients, and especially those with high risk behaviour. Written informed consent of clients before testing was required in 20-32% of clinics. Almost all health advisers (136, 98%) and physicians (103, 99%) said they had given pretest counselling (data not shown), but proportionately more health advisers had received training in counselling than physicians.
Sixty three per cent of all respondents had available written guidelines for counselling HIV infected patients, usually drawn up by clinic staff, only 24% of which contained recommendations for notifying partners (data not shown). BMJ VOLUME 305 When counselling patients before testing, about half of the physicians and two thirds of the health advisers discussed partner notification routinely and there were no differences between Thames and outside regions. A high percentage in both groups (98% and 81%) also encouraged HIV infected patients to inform their contacts after testing but far fewer (55% and 58%) offered their services for referring contacts if clients were reluctant to do so themselves. Again, significantly fewer staff in the Thames regions than elsewhere (11/25 (44%) of physicians and 10/34 (29%) of health advisers compared with almost two thirds (109/172, 63%) in both groups elsewhere) would offer these services (p=0 0002).
Opinions about the probable effectiveness of notification of partners varied. Most physicians and health advisers agreed that early intervention could benefit persons with asymptomatic HIV infection. They disagreed, however, with the statement that people are generally well enough informed about the risks of HIV infection and therefore would not benefit from extra counselling. Health advisers were significantly more likely than physicians to agree that informing contacts was of no value in controlling the epidemic and would deter clinic attendance, threaten confidentiality, undermine the professional-client relationship, and make informed contacts unnecessarily anxious (table II) .
Physicians seemed more likely than health advisers to agree that contacts have a right to know of their exposure, although this was not significant. Health advisers were more likely to agree that contacts had a right not to know, but they were also more undecided about this (questions 7, 8) . Opinions were divided about the responsibility of patients to inform their contacts (question 9). However, a higher percentage of health advisers in the Thames regions than elsewhere (21/36 (58%) v 30/105 (29%)) believed that only patients should do this. Health advisers were also significantly more likely than physicians to agree that existing services could not meet an increased demand for partner referral (questions 10, 11).
When presented with several scenarios of HIV exposure a significantly higher proportion of physicians than health advisers in each case agreed that the contacts should be informed, but in most cases a higher proportion of health advisers were uncertain in their replies (table III) . In the Thames regions up to 45% fewer health advisers than physicians agreed; indeed, between 19% and 25% (seven and nine) of the 36 health advisers in the Thames regions and between 4% and 8% of the 105 in the other regions refused to respond to these questions.
Discussion
Counselling and testing for HIV infection is widely available in genitourinary medicine clinics in the United Kingdom, and staff generally agree that notification of partners is important, although they are reluctant to become directly involved. The health advisers, whose traditional role has been to promote referral of partners, are particularly sceptical, especially those in the Thames regions. Elsewhere, in low prevalence areas, staff seem to favour a more traditional approach, in which health advisers are directly involved in notification.
The differences of opinion we observed between the physicians or supervisors and the counsellors, although striking, may not be typical of the profession and should be interpreted with caution. represented. This may be particularly true in the Thames regions, which have the highest concentrations of counsellors and people with HIV or AIDS but the lowest response rates in the study. The regional differences in attitudes and practices are probably a reflection of clinic workloads, the mix of HIV Although the physicians and health advisers seemed reluctant to be directly involved in partner notification for HIV infection, there is evidence that patients attending genitourinary medicine clinics are far less opposed to it. In a recent pilot study of the attitudes of 75 clients attending a general genitourinary medicine clinic in London over three quarters of women and half of men felt that notifying partners in HIV infection should be standard practice and were not unduly concerned about its potential impact on themselves or their contacts (S Wanigaratne, personal communication).
USEFULNESS OF PARTNER NOTIFICATION
Internationally and in the United Kingdom AIDS from heterosexual exposure is increasing at a faster rate than that from male homosexual exposure and injecting drug use, a trend especially affecting women and children. There is therefore an urgent need to re-examine the usefulness of notifying partners in HIV infection, especially in situations in which contacts may be unaware of their exposure and risk.
Because of the apparent confusion surrounding this issue in the United Kingdom we recommend that there should be national guidelines for notifying partners for areas of low and high HIV prevalence, especially for people who may be unaware of their exposure and auditing of the effectiveness of current practices in genitourinary medicine clinics with focused operational research into cost effectiveness and cost benefit of notifying partners. This will involve reviving the alliance between clinicians, policy makers, epidemiologists, and patient advocates to establish well justified policies appropriate for the United Kingdom to develop rational programmes for the prevention of new HIV infections and management of those already infected.
